Trailing-twelve-month (TTM) revenue is $3.33 Billion with a year-over-year growth of +12.39%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $804,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-23 |
| Q4 FY2025Period ended 2025-12-31 | $805,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-17 |
| Q1 FY2026Period ended 2026-03-31 | $844,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-23 |
| Q2 FY2026Period ended 2026-06-30 | $872,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-23 |
| TTM revenue | $3,326,500,000 |
Current P/S: $26,059,454,982 market capitalization ÷ $3,326,500,000 TTM revenue = 7.83x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $872.30M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:16:17.710Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Contract Manufactured Products | $499M | $515M | $480M | $553M | $559M | $582M |
| Proprietary Products | N/A | $2.3B | $2.4B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| FRANCE | $173M | $213M | $238M | $283M | $242M | $227M |
| GERMANY | $282M | $474M | $399M | $406M |
$3.33B
$3.33 Billion
+12.39%
vs. $2.96B a year ago (TTM)
+5.68%
5 Year compound annual growth rate
1 Year
+12.39%
3 Year
+5.10%
5 Year
+5.68%
10 Year
+8.63%
15 Year
+7.33%
20 Year
+7.12%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.07B | +$181.00M | +6.26% |
| 2024 | $2.89B | ($58.40M) | (1.98%) |
| 2023 | $2.95B | +$65.60M | +2.27% |
| 2022 | $2.89B | +$54.80M | +1.94% |
| 2021 | $2.83B | +$684.00M | +31.86% |
| 2020 |
TTM Growth
+12.39%
3-Year CAGR
+5.10%
5-Year CAGR
+5.68%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-26T00:16:17.710Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.4B |
| $2.3B |
| $2.5B |
| $380M |
| IRELAND | $226M | $248M | $240M | $286M | $323M | $333M |
|---|
| Other Countries | $254M | $357M | $364M | $349M | $339M | $353M |
|---|
| Other Europe Countries | $237M | $341M | $359M | $388M | $386M | $451M |
|---|
| UNITED STATES | $976M | $1.2B | $1.3B | $1.2B | $1.2B | $1.3B |
|---|
| $2.15B |
| +$303.10M |
| +16.44% |
| 2019 | $1.84B | +$125.60M | +7.31% |
| 2018 | $1.72B | +$117.80M | +7.36% |
| 2017 | $1.60B | +$91.10M | +6.04% |
| 2016 | $1.51B | +$111.10M | +7.95% |
